VIR Vir Biotechnology, Inc.
Nasdaq · SEC CIK 1706431 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $21.00M 38 sales by 10 insiders
- Filings on record
- 298 since 2021-07-06, latest 2026-08-12 14:30
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| SVF Endurance (Cayman) Ltd | 10% | — | $9.38M |
| SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $5.72M |
| SOFTBANK VISION FUND (AIV M1) L.P. | 10% | — | $2.76M |
| SATO VICKI L | Dir | — | $1.73M |
| De Backer Marianne | Pres, CEO, Dir | — | $946.9K |
| de Verneuil Vanina | EVP, GC, Corp Sec | — | $217.7K |
| Sabatini Brent | SVP, CAO | — | $113.1K |
| O'Byrne Jason | EVP, CFO | — | $68.9K |
| Eisner Mark | EVP, Chief Medical Off | — | $49.5K |
| Napolitano Janet | Dir | — | $30.2K |
Transactions 390
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-12-29 | 2022-12-27 | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $25.59 | -6,850 | 20.30M | -0.0% | -$175.3K |
| MI | 2022-12-27 | 2022-12-22+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $25.93 | -175.2K | 20.46M | -0.8% | -$4.54M |
| MI | 2022-12-22 | 2022-12-20+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $25.84 | -215.8K | 20.60M | -1% | -$5.58M |
| 2022-12-09 | 2022-12-08 | VIR | SATO VICKI L | Dir | S - Sale | $25.81 | -17.9K | 1.38M | -1% | -$462.4K | |
| MI | 2022-12-06 | 2022-12-02+ | VIR | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | S - Sale | $27.45 | -97.3K | 20.70M | -0.5% | -$2.67M |
| MI | 2022-12-02 | 2022-11-30+ | VIR | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | S - Sale | $27.77 | -212.3K | 20.85M | -1% | -$5.90M |
| MI | 2022-11-30 | 2022-11-28+ | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $27.42 | -109.1K | 21.08M | -0.5% | -$2.99M |
| MI | 2022-11-28 | 2022-11-23+ | VIR | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | S - Sale | $27.27 | -57.0K | 21.14M | -0.3% | -$1.55M |
| I | 2022-11-23 | 2022-11-22 | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $27.27 | -65.2K | 21.18M | -0.3% | -$1.78M |
| MI | 2022-11-22 | 2022-11-18+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $27.21 | -26.0K | 21.24M | -0.1% | -$706.8K |
| MI | 2022-11-18 | 2022-11-16+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $27.42 | -210.0K | 21.34M | -1.0% | -$5.76M |
| MI | 2022-11-16 | 2022-11-14+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $27.61 | -138.0K | 21.57M | -0.6% | -$3.81M |
| MI | 2022-11-14 | 2022-11-09+ | VIR | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | S - Sale | $27.30 | -287.7K | 21.90M | -1% | -$7.86M |
| MI | 2022-11-09 | 2022-11-07+ | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $27.26 | -182.1K | 21.95M | -0.8% | -$4.96M |
| 2022-11-09 | 2022-11-08 | VIR | SATO VICKI L | Dir | S - Sale | $27.38 | -17.9K | 1.40M | -1% | -$490.5K | |
| 2022-10-11 | 2022-10-10 | VIR | SATO VICKI L | Dir | S - Sale | $20.67 | -17.9K | 1.42M | -1% | -$370.3K | |
| 2022-09-09 | 2022-09-08 | VIR | SATO VICKI L | Dir | S - Sale | $21.90 | -17.9K | 1.43M | -1% | -$392.3K | |
| MI | 2022-09-07 | 2022-09-02+ | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -996.6K | 5.63M | -15% | $0 |
| M | 2022-09-07 | 2022-09-02+ | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +55.0K | 570.1K | +11% | $0 |
| MI | 2022-09-07 | 2022-09-02+ | VIR | ARCH Venture Partners IX, L.P. | 10% | J - Other | $0.00 | -994.1K | 5.87M | -14% | $0 |
| M | 2022-09-07 | 2022-09-02+ | VIR | ARCH Venture Partners IX, L.P. | 10% | J - Other | $0.00 | +29.1K | 258.6K | +13% | $0 |
| MI | 2022-09-01 | 2022-08-30+ | VIR | CRANDELL KEITH | 10% | J - Other | $0.00 | -994.1K | 52.3K | -95% | $0 |
| M | 2022-09-01 | 2022-08-30+ | VIR | CRANDELL KEITH | 10% | J - Other | $0.00 | +29.1K | 27.6K | New | $0 |
| M | 2022-09-01 | 2022-08-30+ | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +55.0K | 515.1K | +12% | $0 |
| MI | 2022-09-01 | 2022-08-30+ | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -996.6K | 8.14M | -11% | $0 |
| MI | 2022-08-26 | 2022-08-24+ | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -996.6K | 6.71M | -13% | $0 |
| M | 2022-08-26 | 2022-08-24+ | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +55.0K | 460.2K | +14% | $0 |
| MI | 2022-08-26 | 2022-08-24+ | VIR | ARCH Venture Fund IX, L.P. | 10% | J - Other | $0.00 | -994.1K | 6.71M | -13% | $0 |
| M | 2022-08-26 | 2022-08-24+ | VIR | ARCH Venture Fund IX, L.P. | 10% | J - Other | $0.00 | +29.1K | 23.2K | New | $0 |
| M | 2022-08-22 | 2022-08-18 | VIR | BYBEE CLINTON | 10% | J - Other | $0.00 | +14.6K | 21.7K | +203% | $0 |
| MI | 2022-08-22 | 2022-08-18 | VIR | BYBEE CLINTON | 10% | J - Other | $0.00 | -497.0K | 6.93M | -7% | $0 |
| MI | 2022-08-22 | 2022-08-18 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -498.3K | 23.8K | -95% | $0 |
| 2022-08-22 | 2022-08-18 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +27.5K | 405.2K | +7% | $0 | |
| MI | 2022-08-17 | 2022-08-15+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $27.97 | -130.4K | 22.09M | -0.6% | -$3.65M |
| MI | 2022-08-16 | 2022-08-12+ | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -1.49M | 9.55M | -14% | $0 |
| M | 2022-08-16 | 2022-08-12+ | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +82.5K | 350.2K | +31% | $0 |
| MI | 2022-08-16 | 2022-08-12+ | VIR | ARCH Venture Fund IX, L.P. | 10% | J - Other | $0.00 | -1.49M | 40.5K | -97% | $0 |
| M | 2022-08-16 | 2022-08-12+ | VIR | ARCH Venture Fund IX, L.P. | 10% | J - Other | $0.00 | +43.7K | 155.3K | +39% | $0 |
| DM | 2022-08-10 | 2022-08-09 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $2.43 | +78.1K | 262.5K | +42% | +$189.7K |
| 2022-08-09 | 2022-08-08 | VIR | SATO VICKI L | Dir | S - Sale | $30.29 | -17.9K | 1.45M | -1% | -$542.6K | |
| D | 2022-07-21 | 2022-07-20 | VIR | Pang Phillip | Chief Medical Off | A - Grant | $1.58 | +5,000 | 149.0K | +3% | +$7,900 |
| D | 2022-07-21 | 2022-07-20 | VIR | Pang Phillip | Chief Medical Off | S - Sale | $30.00 | -5,000 | 144.0K | -3% | -$150.0K |
| D | 2022-07-13 | 2022-07-11 | VIR | Ramasastry Saira | Dir | A - Grant | $12.76 | +5,000 | 13.1K | +62% | +$63.8K |
| D | 2022-07-13 | 2022-07-11 | VIR | Ramasastry Saira | Dir | S - Sale | $30.00 | -5,000 | 8,092 | -38% | -$150.0K |
| M | 2022-07-12 | 2022-07-08 | VIR | SATO VICKI L | Dir | S - Sale | $29.07 | -17.9K | 1.47M | -1% | -$520.8K |
| 2022-06-22 | 2022-04-15 | VIR | Pang Phillip | Chief Medical Off | G - Gift | $0.00 | -7,777 | 149.0K | -5% | $0 | |
| 2022-06-22 | 2022-06-21 | VIR | Pang Phillip | Chief Medical Off | S - Sale | $24.89 | -4,991 | 144.0K | -3% | -$124.2K | |
| I | 2022-06-13 | 2022-06-09 | VIR | MORE ROBERT J | Dir | J - Other | $0.00 | +3,374 | 489.5K | +0.7% | $0 |
| 2022-06-13 | 2022-06-09 | VIR | MORE ROBERT J | Dir | J - Other | $0.00 | -3,374 | 39.1K | -8% | $0 | |
| M | 2022-06-10 | 2022-06-08 | VIR | ARCH Venture Partners IX Overage, L.P. | 10% | J - Other | $0.00 | +14.6K | 15.8K | +1,158% | $0 |
| MI | 2022-06-10 | 2022-06-08 | VIR | ARCH Venture Partners IX Overage, L.P. | 10% | J - Other | $0.00 | -497.0K | 7.80M | -6% | $0 |
| MI | 2022-06-10 | 2022-06-08 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -498.3K | 10.11M | -5% | $0 |
| 2022-06-10 | 2022-06-08 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +27.5K | 295.2K | +10% | $0 | |
| M | 2022-06-09 | 2022-06-08 | VIR | SATO VICKI L | Dir | S - Sale | $25.84 | -17.9K | 1.49M | -1% | -$462.9K |
| MI | 2022-06-06 | 2022-06-02 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -500.0K | 10.40M | -5% | $0 |
| 2022-06-06 | 2022-06-02 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +29.2K | 283.1K | +11% | $0 | |
| MI | 2022-06-06 | 2022-06-02 | VIR | ARCH Venture Partners IX, LLC | 10% | J - Other | $0.00 | -500.0K | 10.40M | -5% | $0 |
| M | 2022-06-06 | 2022-06-02 | VIR | ARCH Venture Partners IX, LLC | 10% | J - Other | $0.00 | +17.5K | 43.0K | +69% | $0 |
| D | 2022-05-25 | 2022-05-23 | VIR | NELSEN ROBERT | Dir, 10% | A - Grant | $0.00 | +6,405 | 254.0K | +3% | $0 |
| D | 2022-05-25 | 2022-05-23 | VIR | MORE ROBERT J | Dir | A - Grant | $0.00 | +6,405 | 42.4K | +18% | $0 |
| D | 2022-05-25 | 2022-05-23 | VIR | Napolitano Janet | Dir | A - Grant | $0.00 | +6,405 | 9,779 | +190% | $0 |
| D | 2022-05-25 | 2022-05-23 | VIR | Hatfield Jeffrey S. | Dir | A - Grant | $0.00 | +6,405 | 9,779 | +190% | $0 |
| D | 2022-05-25 | 2022-05-23 | VIR | Sigal Charles Elliott | Dir | A - Grant | $0.00 | +6,405 | 9,779 | +190% | $0 |
| D | 2022-05-25 | 2022-05-23 | VIR | SHARP PHILLIP A | Dir | A - Grant | $0.00 | +6,405 | 115.1K | +6% | $0 |
| D | 2022-05-25 | 2022-05-23 | VIR | PEREZ ROBERT J | Dir | A - Grant | $0.00 | +6,405 | 9,779 | +190% | $0 |
| D | 2022-05-25 | 2022-05-23 | VIR | Ramasastry Saira | Dir | A - Grant | $0.00 | +6,405 | 9,779 | +190% | $0 |
| D | 2022-05-25 | 2022-05-24 | VIR | Ramasastry Saira | Dir | S - Sale | $23.82 | -1,687 | 8,092 | -17% | -$40.2K |
| D | 2022-05-25 | 2022-05-24 | VIR | SATO VICKI L | Dir | S - Sale | $23.82 | -3,374 | 1.51M | -0.2% | -$80.4K |
| D | 2022-05-25 | 2022-05-23 | VIR | SATO VICKI L | Dir | A - Grant | $0.00 | +6,405 | 1.51M | +0.4% | $0 |
| 2022-05-10 | 2022-05-09 | VIR | SATO VICKI L | Dir | S - Sale | $20.62 | -14.5K | 1.50M | -1.0% | -$299.8K | |
| A | 2022-05-10 | 2021-12-20 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +102.0K | 247.5K | +70% | $0 |
| M | 2022-05-02 | 2022-04-28 | VIR | SATO VICKI L | Dir | S - Sale | $20.90 | -17.9K | 1.52M | -1% | -$374.4K |
| D | 2022-04-06 | 2022-03-10 | VIR | SCANGOS GEORGE A | Pres, CEO, Dir | A - Grant | $0.00 | +111.0K | 224.0K | +98% | $0 |
| 2022-03-31 | 2022-03-30 | VIR | HANLY ANN M. | CTO | S - Sale | $26.24 | -2,627 | 81.5K | -3% | -$68.9K | |
| D | 2022-03-11 | 2022-03-10 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +9,000 | 184.4K | +5% | +$13.8K |
| D | 2022-03-08 | 2022-03-02 | VIR | Friedl-Naderer Johanna | Chief Business Off, Gbl | A - Grant | $0.00 | +90.0K | 90.0K | New | $0 |
| D | 2022-02-24 | 2022-02-22 | VIR | Rice Steven J. | Chief Administrative Off | A - Grant | $0.00 | +20.0K | 38.7K | +107% | $0 |
| D | 2022-02-24 | 2022-02-22 | VIR | Horn Howard | CFO | A - Grant | $0.00 | +35.0K | 235.4K | +17% | $0 |
| D | 2022-02-24 | 2022-02-22 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 176.8K | +0.8% | +$2,104 |
| D | 2022-02-24 | 2022-02-22 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $30.00 | -1,375 | 175.4K | -0.8% | -$41.2K |
| D | 2022-02-24 | 2022-02-22 | VIR | Virgin Herbert | EVP, CSO, Research | A - Grant | $0.00 | +70.0K | 175.4K | +66% | $0 |
| D | 2022-02-24 | 2022-02-22 | VIR | Pang Phillip | Chief Medical Off | A - Grant | $0.00 | +67.0K | 156.8K | +75% | $0 |
| D | 2022-02-24 | 2022-02-22 | VIR | HANLY ANN M. | CTO | A - Grant | $0.00 | +53.5K | 84.1K | +175% | $0 |
| 2022-02-22 | 2022-02-17 | VIR | Horn Howard | CFO | S - Sale | $31.93 | -2,393 | 200.4K | -1% | -$76.4K | |
| 2022-02-22 | 2022-02-17 | VIR | Rice Steven J. | Chief Administrative Off | S - Sale | $31.93 | -1,942 | 18.7K | -9% | -$62.0K | |
| M | 2022-02-22 | 2022-02-17+ | VIR | SCANGOS GEORGE A | Pres, CEO, Dir | S - Sale | $31.11 | -27.8K | 130.7K | -18% | -$863.4K |
| 2022-02-22 | 2022-02-17 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale | $31.93 | -2,293 | 105.4K | -2% | -$73.2K | |
| D | 2022-02-18 | 2022-02-16 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $1.53 | +5,000 | 97.8K | +5% | +$7,650 |
| DM | 2022-02-18 | 2022-02-16+ | VIR | Pang Phillip | Chief Medical Off | S - Sale+OE | $31.69 | -8,009 | 89.8K | -8% | -$253.8K |
| D | 2022-02-09 | 2022-02-08 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 109.1K | +1% | +$2,104 |
| D | 2022-02-09 | 2022-02-08 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $33.94 | -1,375 | 107.7K | -1% | -$46.7K |
| D | 2022-02-04 | 2022-02-02 | VIR | Pang Phillip | Chief Medical Off | S - Sale+OE | $34.52 | -5,000 | 92.8K | -5% | -$172.6K |
| D | 2022-02-04 | 2022-02-02 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $1.53 | +5,000 | 97.8K | +5% | +$7,650 |
| D | 2022-01-26 | 2022-01-25 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $32.46 | -1,375 | 107.7K | -1% | -$44.6K |
| D | 2022-01-26 | 2022-01-25 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 109.1K | +1% | +$2,104 |
| D | 2022-01-20 | 2022-01-19 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $1.53 | +5,000 | 97.8K | +5% | +$7,650 |
| DM | 2022-01-20 | 2022-01-19 | VIR | Pang Phillip | Chief Medical Off | S - Sale+OE | $35.06 | -5,000 | 95.3K | -5% | -$175.3K |
| 2022-01-20 | 2022-01-18 | VIR | SATO VICKI L | Dir | S - Sale | $37.39 | -15.2K | 1.54M | -1.0% | -$567.3K | |
| D | 2022-01-13 | 2022-01-11 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $35.10 | -1,375 | 107.7K | -1% | -$48.3K |
| D | 2022-01-13 | 2022-01-11 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 109.1K | +1% | +$2,104 |
Purchase Sale Sale after option exercise All abbreviations